Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Nutrients ; 15(2)2023 Jan 09.
Article in English | MEDLINE | ID: mdl-36678202

ABSTRACT

Bacterial vaginosis (BV) is the most common disease in women of childbearing age and is caused by the growth of abnormal microbiota in the vagina. Probiotic consumption can be an effective alternative treatment to preserve or improve vaginal health. In the present study, MED-01, a complex of five strains of probiotic candidates isolated from the vagina of Korean women, was used. This study was designed as a 12-week, randomized, multicenter, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of MED-01 on vaginal health. A total of 101 reproductive-aged women with a Nugent score of 4-6 took MED-01 (5.0 × 109 CFU) or a placebo once a day, and 76 participants completed the procedure. MED-01 significantly reduced the Nugent score compared with the placebo. Quantitative PCR analysis confirmed that Lactobacillus plantarum was significantly increased in the vagina, whereas harmful bacteria such as Mobiluncus spp., Gardnerella vaginalis, and Atopobium vaginae were suppressed after 12 weeks of MED-01 ingestion. No adverse events to the test food supplements were observed in the participants. These results confirmed that MED-01 can be used as a probiotic for treating BV, as it improves the vaginal microbiota.


Subject(s)
Probiotics , Vaginosis, Bacterial , Female , Humans , Adult , Vagina/microbiology , Vaginosis, Bacterial/microbiology , Gardnerella vaginalis , Dietary Supplements
2.
BMC Womens Health ; 22(1): 439, 2022 11 08.
Article in English | MEDLINE | ID: mdl-36348333

ABSTRACT

BACKGROUND: Polycystic ovary syndrome (PCOS) is a common endocrine disorder associated with an increased risk of other gynecological disorders, such as endometrial hyperplasia (EH). However, substantial factors in the comorbidity of EH and PCOS remain to be investigated. We analyzed trend changes in PCOS and factors related to the comorbidity of PCOS and EH using data from the Korea National Health Insurance (KNHI) claims database. METHODS: The data for this population-based study of people diagnosed with PCOS or EH in Korea from 2009 to 2016 were collected from the KNHI claims database between 2007 and 2017. We conducted a trend analysis of the prevalence and incidence of PCOS and EH. In addition, we performed a logistic regression analysis to identify risk factors associated with EH incidence in people with PCOS using the matched case-control methodology. RESULTS: The average annual growth rate of the incidence of PCOS was 14.1% from 2009 to 2016, whereas the EH rate increased by only 3.4% annually. Comorbidities, type 2 diabetes, obesity, hypertension, hyperlipidemia, and infertility, increased the risk of EH in PCOS patients. Additionally, the cumulative duration of oral contraceptive & progestin treatment for PCOS correlated highly with the comorbidity of EH and PCOS. CONCLUSIONS: We confirmed the relationship between PCOS and EH using big data suitable for time series analyses of the diagnosis and treatment of diseases. Endometrial evaluation should be done with more caution if oral contraceptives & progestins have been used for a long time.


Subject(s)
Diabetes Mellitus, Type 2 , Endometrial Hyperplasia , Polycystic Ovary Syndrome , Female , Humans , Polycystic Ovary Syndrome/complications , Endometrial Hyperplasia/epidemiology , Endometrial Hyperplasia/complications , Diabetes Mellitus, Type 2/complications , Factor Analysis, Statistical , National Health Programs
3.
Carbohydr Polym ; 247: 116696, 2020 Nov 01.
Article in English | MEDLINE | ID: mdl-32829824

ABSTRACT

Antimicrobial starch/gum-based edible emulsion coatings were developed to improve the storage stability of rice cakes by retarding starch retrogradation and inhibiting microbial growth. Rice cakes were coated with mung bean starch (MBS) and guar gum (GG) containing various concentrations of sunflower seed oil (SO). Among these, the (2 g MBS +0.75 g GG +1.5 g SO) / 100 g (optimum) decreased the hardness of rice cakes by 29 % and the crystallization rate (k) by 24 % compared with those of uncoated samples. The moisture loss in uncoated samples was markedly higher than that in the optimum blend-coated samples. Crystallinity analysis revealed the retarding effect of the developed coatings in starch retrogradation. Furthermore, adding 0.8 % (w/w) grapefruit seed extract to the optimum blend led to a distinct antimicrobial activity. Therefore, the newly developed edible coating was effective in maintaining the quality and safety of rice cakes.


Subject(s)
Anti-Infective Agents/chemistry , Emulsions/chemistry , Food Safety/methods , Galactans/chemistry , Mannans/chemistry , Plant Gums/chemistry , Starch/chemistry , Vigna/chemistry , Anti-Infective Agents/pharmacology , Bacillus cereus/drug effects , Bacillus cereus/growth & development , Calorimetry, Differential Scanning , Edible Films , Emulsions/pharmacology , Food Preservation/methods , Galactans/pharmacology , Hardness , Kinetics , Mannans/pharmacology , Microscopy, Electron, Scanning , Oryza/chemistry , Oryza/metabolism , Penicillium/drug effects , Penicillium/growth & development , Plant Gums/pharmacology , Seeds/chemistry , Starch/pharmacology , Sunflower Oil/chemistry , Water/analysis , Water/chemistry , X-Ray Diffraction
4.
J Med Food ; 13(1): 1-5, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20136429

ABSTRACT

Lipid-soluble ginseng extract was prepared by n-hexane extraction of red ginseng. BALB/c-nu mice were inoculated with human lung cancer (NCI-H460) cells to establish a human tumor xenograft model in nude mice, and the lipid-soluble ginseng extract was orally administered. The tumor inhibitory rates of the lipid-soluble ginseng extract at doses of 0.1, 0.3, and 1.0 g/kg/day were 18.9% (P < .05), 60.0% (P < .001), and 67.5% (P < .001), respectively. The oral administration of the lipid-soluble extract of red ginseng showed a potent anticancer effect in nude mice bearing human lung cancer cells in a dose-dependent manner without any apparent toxicity. This lipid-soluble ginseng extract is a potential nontoxic anticancer supplement for the prevention and intervention of lung tumor growth through an oral administration route.


Subject(s)
Antineoplastic Agents, Phytogenic/therapeutic use , Cell Proliferation/drug effects , Lung Neoplasms/drug therapy , Panax , Phytotherapy , Plant Extracts/therapeutic use , Animals , Antineoplastic Agents, Phytogenic/pharmacology , Cell Line, Tumor , Disease Models, Animal , Dose-Response Relationship, Drug , Female , Humans , Lipids , Mice , Mice, Inbred BALB C , Mice, Nude , Plant Extracts/pharmacology , Solubility , Xenograft Model Antitumor Assays
5.
Asia Pac J Clin Nutr ; 18(1): 29-33, 2009.
Article in English | MEDLINE | ID: mdl-19329392

ABSTRACT

OBJECTIVE: To determine the vitamin D status of Korean postmenopausal women during the winter months according to the intake of vitamin D supplements. DESIGN: Cross sectional study of serum 25(OH)D levels according to the intake of vitamin D supplements in postmenopausal women. METHOD: Between November 2006 and February 2007, 254 postmenopausal women who visited our menopausal clinic for hormone therapy or osteoporosis medication were recruited. Serum 25(OH)D levels were measured with a radioimmunoassay kit and the results were compared among groups that were classified according to the intake amount of vitamin D supplements. RESULTS: The mean serum 25(OH)D level was 83.3 +/- 32.8 nmol/L and it increased as the intake amount of vitamin D supplements increased. The mean serum 25(OH)D level was not significantly different between groups 1 (no vitamin D supplements) and 2 (daily 100-300 IU supplements). However, the mean serum 25(OH)D level was significantly higher in group 3 (daily 400 IU supplements) than in group 1. While the mean value of group 4 (daily 600 IU) was not significantly different from that of group 3, it was significantly lower than that of group 5 (daily 800-900 IU). CONCLUSION: Vitamin D supplementation is highly effective in improving vitamin D status and the vitamin D status in this study population was improved considerably when compared to previous studies. Therefore, it is concluded that the prevalence of vitamin D insufficiency should be re-evaluated in postmenopausal women in most countries including Korea.


Subject(s)
Calcifediol/blood , Postmenopause/blood , Vitamin D Deficiency/drug therapy , Vitamin D/therapeutic use , Vitamins/therapeutic use , Aged , Dietary Supplements , Female , Humans , Korea/epidemiology , Middle Aged , Prevalence , Vitamin D/blood , Vitamin D Deficiency/epidemiology , Vitamins/blood
6.
J Ethnopharmacol ; 84(2-3): 193-8, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12648815

ABSTRACT

The present study was conducted to evaluate the immunomodulatory effect of aqueous-extracted Astragali radix (ARE) in methotrexate (MTX)-treated mouse spleen cells. In spleen cell proliferation assay, ARE enhanced mitogenic activity in the dose-response manner. We also investigated the effect of ARE on the reducing of immune suppression caused by MTX in mouse spleen cells. MTX decreased the spleen cell proliferation (IC(50):800 microg/ml). However, ARE significantly reduced the suppression of cell proliferation by MTX in mouse spleen cells. Immunomodulatory effect of ARE were further investigated using reverse transcription polymerase chain reaction (RT-PCR). In RT-PCR, we examined the expressions of various cytokines such as IL-6, IL-1alpha, IL-1beta, IL-12p40, GM-CSF and TNF. Enhancement of IL-1alpha and IL-12p40 mRNA expressions were shown in mouse spleen cells by ARE. In spite of MTX treatment, the expressions of IL-1alpha and IL-12p40 mRNA sustained in spleen cells. These data indicate that (1) ARE has a protective effect of immune suppression, and (2) the immunomodulatory effects of ARE may be, in part, associated with the expressions of IL-1alpha and IL-12p40 mRNA as well as the mitogenic effect on spleen cells.


Subject(s)
Adjuvants, Immunologic/pharmacology , Fabaceae/chemistry , Immunosuppressive Agents/pharmacology , Methotrexate/pharmacology , Spleen/cytology , Spleen/immunology , Animals , Body Weight/drug effects , Cell Division/drug effects , Cell Separation , Cytokines/biosynthesis , Dose-Response Relationship, Drug , Female , Gene Expression Regulation/drug effects , Mice , Mice, Inbred ICR , Mitogens/pharmacology , Oligonucleotide Probes/pharmacology , Organ Size/drug effects , Plant Extracts/pharmacology , RNA/isolation & purification , Reverse Transcriptase Polymerase Chain Reaction , Spleen/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL